Shourong Liu

774 total citations
52 papers, 457 citations indexed

About

Shourong Liu is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Shourong Liu has authored 52 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 13 papers in Molecular Biology and 11 papers in Infectious Diseases. Recurrent topics in Shourong Liu's work include Liver Disease Diagnosis and Treatment (10 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Shourong Liu is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Shourong Liu collaborates with scholars based in China, Australia and United States. Shourong Liu's co-authors include Rangxiao Zhuang, Jianjun Xi, Tingting Shi, Ruoyu He, Zhaobin Cai, Yanmei Zhao, Xingxin Yang, Jiankang Zhang, Wenjun Ma and Zhaoyi Li and has published in prestigious journals such as PLoS ONE, Chemical Communications and Frontiers in Immunology.

In The Last Decade

Shourong Liu

47 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shourong Liu China 14 155 148 57 52 46 52 457
Yasmine Ibrahim Egypt 13 140 0.9× 155 1.0× 133 2.3× 32 0.6× 19 0.4× 26 601
Hongyang Liu China 14 87 0.6× 189 1.3× 95 1.7× 28 0.5× 15 0.3× 37 528
Qianzhou Lv China 13 94 0.6× 112 0.8× 23 0.4× 18 0.3× 21 0.5× 41 428
Ahmed A. Shaaban Egypt 14 83 0.5× 173 1.2× 69 1.2× 65 1.3× 24 0.5× 31 497
Riyasat Ali India 13 104 0.7× 139 0.9× 49 0.9× 9 0.2× 40 0.9× 26 500
Shaoqi Yang China 13 204 1.3× 409 2.8× 32 0.6× 86 1.7× 19 0.4× 37 768
Kui Yang China 15 107 0.7× 133 0.9× 78 1.4× 28 0.5× 22 0.5× 31 538
Nannan Liu China 15 162 1.0× 267 1.8× 55 1.0× 33 0.6× 6 0.1× 48 656
Amy M. Bataille United States 8 134 0.9× 161 1.1× 54 0.9× 60 1.2× 11 0.2× 10 396

Countries citing papers authored by Shourong Liu

Since Specialization
Citations

This map shows the geographic impact of Shourong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shourong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shourong Liu more than expected).

Fields of papers citing papers by Shourong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shourong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shourong Liu. The network helps show where Shourong Liu may publish in the future.

Co-authorship network of co-authors of Shourong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shourong Liu. A scholar is included among the top collaborators of Shourong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shourong Liu. Shourong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiao, Tong, Lu Zhang, Yu Cao, et al.. (2025). A “turn-on” fluorescence polyethyleneimine-based nanosensor chemosensor for sensing of l-lysine. Talanta. 293. 128045–128045.
2.
Zhang, Lu, Yu Cao, Tong Qiao, et al.. (2025). Small nucleic acid drugs-the dawn of functional cure of chronic hepatitis B. Frontiers in Pharmacology. 16. 1633001–1633001.
3.
4.
Wang, Yi, Wenhui Zhang, Shourong Liu, et al.. (2024). Diagnostic Value of SAA Levels and Perianal Symptoms in the Complicated Perianal Abscesses Among Mpox-Infected Patients. Journal of Inflammation Research. Volume 17. 6239–6250. 2 indexed citations
5.
6.
Zhang, Wenhui, et al.. (2023). Dynamics of CD4+ T-Cells and Neutralizing Antibody Responses to Three Consecutive Doses of Inactivated COVID-19 Vaccines in PLWH. Infection and Drug Resistance. Volume 16. 2695–2707. 5 indexed citations
7.
8.
Wang, Yi, Jianhua Li, Wenhui Zhang, et al.. (2023). Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV. Frontiers in Immunology. 14. 1152695–1152695. 7 indexed citations
9.
Shi, Tao, Chong Zhang, Linghui Zeng, et al.. (2023). Exploration of novel dihydroquinoxalinone derivatives as EGFRL858R/T790M tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer. Bioorganic Chemistry. 135. 106494–106494. 3 indexed citations
10.
Bao, Jianfeng, Shourong Liu, Xiao Liang, et al.. (2022). A prediction model for COVID-19 liver dysfunction in patients with normal hepatic biochemical parameters. Life Science Alliance. 6(1). e202201576–e202201576. 1 indexed citations
11.
Shi, Tingting, Rangxiao Zhuang, Jianjun Xi, et al.. (2021). Regulation of Mitochondrial Function by Natural Products for the Treatment of Metabolic Associated Fatty Liver Disease. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 5527315–5527315. 7 indexed citations
12.
13.
Yang, Hongru, et al.. (2021). Corylin sensitizes breast cancer cells to overcome tamoxifen resistance by regulating OAS1/miR-22-3p/SIRT1 axis. Acta Biochimica Polonica. 68(4). 757–764. 9 indexed citations
14.
He, Di, Mengyan Wang, Wenjun Ma, et al.. (2021). Severity-associated markers and assessment model for predicting the severity of COVID-19: a retrospective study in Hangzhou, China. BMC Infectious Diseases. 21(1). 774–774. 13 indexed citations
15.
Shi, Tingting, Li Wu, Wenjun Ma, et al.. (2020). Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine. Evidence-based Complementary and Alternative Medicine. 2020(1). 8749564–8749564. 45 indexed citations
16.
Zhang, Zhongdong, et al.. (2020). Pathogenic microorganism detection in AIDS patients using bronchoalveolar lavage fluid.. PubMed. 13(7). 1727–1732. 2 indexed citations
17.
Liu, Shourong, Xiaoli Hou, Yue Zhang, et al.. (2020). Adipose-tissue derived porcine mesenchymal stem cells efficiently ameliorate CCl4-induced acute liver failure in mice. Cytotechnology. 72(3). 327–341. 2 indexed citations
18.
Zhang, Jiankang, Jianjun Xi, Ruoyu He, et al.. (2019). Discovery of 3-(thiophen/thiazole-2-ylthio)pyridine derivatives as multitarget anticancer agents. Medicinal Chemistry Research. 28(10). 1633–1647. 6 indexed citations
19.
Xu, Keyang, Shourong Liu, Xu Zhao, et al.. (2018). Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol. Biomedicine & Pharmacotherapy. 110. 844–849. 32 indexed citations
20.
Huang, Qian, et al.. (2016). Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease. Biomedical Reports. 5(2). 188–192. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasmine Ibrahim Breakdown of academic impact, for papers by Hongyang Liu Breakdown of academic impact, for papers by Qianzhou Lv Breakdown of academic impact, for papers by Ahmed A. Shaaban Breakdown of academic impact, for papers by Riyasat Ali Breakdown of academic impact, for papers by Shaoqi Yang Breakdown of academic impact, for papers by Kui Yang Breakdown of academic impact, for papers by Nannan Liu Breakdown of academic impact, for papers by Amy M. Bataille
Rankless by CCL
2026